Website profile

Inside Precision Medicine

Inside Precision Medicine is the only global media brand covering the full spectrum of precision medicine, taking a wide lens approach while bringing into sharp focus the many complex and interconnected issues that constitute the field.

  • 58articles · 30d
  • 2+ day agolatest article
  • Aug 17, 2026earliest in window
  • 98%with images
  • 345avg words
articles per day
Categories
  • Health & Wellness 56
  • Medical 55
  • Health 50
  • Science & Technology 8
  • Science & Nature 3
  • People & Society 1
  • STEM 1

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Inside Precision Medicine
insideprecisionmedicine.com > multimedia > webinars > upcoming > highly-multiplexed-droplet-digital-pcr-for-ultra-sensitive-nsclc-biomarker-detection-in-research-workflows

Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows

3+ day, 13+ hour ago   (361+ words) Inside Precision Medicine Surbhi Jain, PhD, MBBS Surbhi Jain, PhD, MBBS, is a staff scientist at Bio-Rad Laboratories and the R&D lead for the ddPLEX EGFR/KRAS/BRAF multiplexed droplet digital PCR panel. She is focused on developing ddPCR…...

Inside Precision Medicine
insideprecisionmedicine.com > topics > oncology > childhood-chemotherapy-leaves-lasting-dna-damage-in-healthy-tissues

Childhood Chemotherapy Leaves Lasting DNA Damage in Healthy Tissues

3+ day, 18+ hour ago   (322+ words) Scientists have found that certain chemotherapy drugs can age children’s healthy cells, causing the same amount of DNA damage in a short period that would normally accumulate over decades in middle-aged adults. Results published today in Science uncover the extent…...

Inside Precision Medicine
insideprecisionmedicine.com > topics > oncology > how-cancer-causing-proteins-accumulate-may-shape-response-to-protacs

How Cancer-Causing Proteins Accumulate May Shape Response to PROTACs

1+ week, 4+ day ago   (763+ words) The genetic mechanism driving an oncogene could help determine whether a tumor responds to protein-degrading therapies, potentially providing a new consideration for selecting patients for this emerging class of cancer drugs. The results suggest that tumors in which an oncogene…...

Inside Precision Medicine
insideprecisionmedicine.com > topics > oncology > measuring-er-positivity-as-a-spectrum-could-improve-breast-cancer-care

Measuring ER Positivity as a Spectrum Could Improve Breast Cancer Care

2+ week, 4+ day ago   (435+ words) Research from the Karolinska Institute in Sweden shows assessing whether breast cancer tumors are estrogen receptor (ER) positive or not is more accurately measured as a spectrum rather than just classifying them as positive or negative. The researchers used a…...

Inside Precision Medicine
insideprecisionmedicine.com > topics > oncology > prostate-cancer-rewires-amino-acid-metabolism-to-drive-treatment-resistance

Prostate Cancer Rewires Amino Acid Metabolism to Drive Treatment Resistance

3+ week, 3+ day ago   (397+ words) Researchers at Weill Cornell Medicine have identified a previously unknown link between amino acid metabolism and prostate cancer’s resistance to hormone therapy. Published in Nature Metabolism, the preclinical study found that prostate cancer cells can hijack the metabolism of two…...

Inside Precision Medicine
insideprecisionmedicine.com > topics > oncology > ctdna-from-blood-equals-or-bests-tissue-based-tests-in-triple-negative-breast-cancer

ctDNA From Blood Equals or Bests Tissue-Based Tests in Triple Negative Breast Cancer

3+ week, 4+ day ago   (428+ words) A blood-based ctDNA test was just as accurate as using tumor tissue for molecular residual disease detection in triple negative breast cancer, a new U.K. study shows. It helped predict recurrence as quickly or sooner than alternative tumor biopsy-based tests. This…...